Sign In
Buy DECK
$107.36
-3.43 (-3.10%)
At Close: Jun 03, 2026
Teva's stock sinks 10% on False Claims allegations
04:02pm, Tuesday, 18'th Aug 2020
Shares of Teva Pharmaceutical Industries Ltd. undefined tumbled 10.9% in trading on Tuesday after the U.S. government alleged that the drugmaker had...
Fintech Focus For August 19, 2020
12:00am, Tuesday, 18'th Aug 2020
Quote Of The Day: Central bank independence? Gone. - Ben Melkman
Fintech Movers: Despite all the talk surrounding digital transformation and the changes that coronavirus has...
Why I'm Worrying Over A Market Drop
04:22pm, Monday, 17'th Aug 2020
Our overbought indicator reaches rarefied air. It could be a good time to rein in risk by reducing margin and avoiding short-term calls.
Here's Why Deckers (DECK) is a Great Momentum Stock to Buy
04:00pm, Thursday, 13'th Aug 2020
Does Deckers (DECK) have what it takes to be a top stock pick for momentum investors? Let's find out.
Why You Should Care About Deckers Outdoor's (NYSE:DECK) Strong Returns On Capital
12:20pm, Wednesday, 12'th Aug 2020
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? In a perfect world...
How Is Deckers Outdoor's (NYSE:DECK) CEO Compensated?
12:16pm, Wednesday, 12'th Aug 2020
Dave Powers became the CEO of Deckers Outdoor Corporation (NYSE:DECK) in 2016, and we think it's a good time to look...
IPO Update: Harmony Biosciences Seeks $100 Million IPO (Pending:HRMY)
09:45pm, Tuesday, 11'th Aug 2020
Harmony Biosciences intends to raise $100 million in an IPO. The firm is developing and commercializing treatments for narcolepsy and related conditions.
Teva Pharmaceutical Industries (TEVA) – Research Analysts’ Weekly Ratings Changes
01:32am, Tuesday, 11'th Aug 2020
Teva Pharmaceutical Industries (NYSE: TEVA) recently received a number of ratings updates from brokerages and research firms: 8/6/2020 – Teva Pharmaceutical Industries had its price target raised by
Avacta Appoints Therapeutics Chief Development Officer
12:00am, Tuesday, 11'th Aug 2020
Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce the appointment of Neil Bell as Chief Dev
Antares Pharma Appoints Tram Bui as Vice President of Corporate Communications and Investor Relations | MarketScreener
11:01am, Monday, 10'th Aug 2020Antares Pharma Appoints Tram Bui as Vice President of Corporate Communications and Investor Relations
11:00am, Monday, 10'th Aug 2020
Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced the appointment of Tram Bui as Vice President of
Eagle Pharmaceuticals Reports Second Quarter 2020 Results
12:00am, Monday, 10'th Aug 2020
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced financial results for the three and six months ended June 30, 20
3 Big Pharma Stocks With Surprising Cannabis Connections | The Motley Fool
11:45am, Saturday, 08'th Aug 2020
These pharmaceutical giants are already preparing for the possibility of medical marijuana legalization.
10 Stocks to Buy for Your Young Child’s Portfolio
12:02pm, Friday, 07'th Aug 2020
With huge changes over the horizon, these ten companies will likely benefit the most.
